Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the Bladder
Status:
Completed
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
This trial will evaluate the efficacy and safety of combination chemotherapy (paclitaxel,
carboplatin, and gemcitabine) prior to surgery in the treatment of patients with locally
advanced transitional cell cancer of the bladder.
Phase:
Phase 2
Details
Lead Sponsor:
University of Michigan Cancer Center University of Michigan Rogel Cancer Center